Phosphoinositide 3-kinase (PI3-K) expression. Tumorigenesis of epithelial carcinomas in the mouth;Phosphoinositid-3-kinase-(PI3-K) expression. Tumorgenese von piattenepithelkarzinomen der mundhöhle

Pathologe

Volumn 25, Issue 1, 2004, Pages 31-37

  Stahl, U ^a   Wenk, J ^a   Wagener, F ^a   Woenckhaus, J ^a   Gamerdinger, U ^a   Battmann, A ^a   Dreyer, T ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

CAL 27; Cancerogenesis; HNSCC; Immunohistochemistry; Phosphoinositide 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P110; PROTEIN P110ALPHA; PROTEIN P85; PROTEIN P85ALPHA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CELL ADHESION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; EPITHELIUM DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOGENESIS; MOUTH CARCINOMA; PROTEIN EXPRESSION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL MOVEMENT; HUMANS; MOUTH NEOPLASMS; PROTO-ONCOGENES;

EID: 1242294408     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-003-0673-2     Document Type: Article

References (39)

1. Albini A, Iwamoto Y, Kleinman HK et al.(1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
2. Alessi DR, Deak M, Casamayor A et al (1997) 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7: 776-789
3. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I (2000) Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157: 369-375
4. Bohle RM, Bonczkowitz M, Altmannsberger HM, Schulz A (1997) Immunohistochemical double staining of microwave enhanced and nonenhanced nuclear and cytoplasmic antigens. Biotech Histochem 72: 10-15
5. Carpenter CL, Cantley LC (1996) Phosphoinositide 3-kinase and the regulation of cell growth. Biochem Biophys Acta 1288: M11-M16
6. Carpenter CL, Duckworth BC, Auger KR et al. (1990) Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem 265: 19704-19711
7. Chang HW, Aoki M, Fruman D et al. (1997) Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276: 1848-1850
8. Estilo CL, O-Charoenrat P, Ngai IP et al. (2003) The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9: 2300-2306
9. Franke TF, Yang SI, Chan TO et al. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736
10. Frankfurt OS, Krishan A (2001) Enzym-linked-immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening. J Immunol Methods 153: 133-143
11. Gasco M, Crook T (2003) The p53 network in head and neck cancer. Oral Oncol 39: 222-231
12. Gioanni J, Fischel JL, Lambert JC et al. (1988) Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24: 1445-1455
13. Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB (2000) In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).Clin Cancer Res 6: 880-886
14. Hu P, Margolis B, Skolnik EY et al. (1992) Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol 12: 981-990
15. Hynes RO (1992) Specificity of cell adhesion in development: the cadherin superfamily. Curr Opin Genet Dev 2: 621-624
16. Jimenez C, Hernandez C, Pimentel B, Carrera AC (2002) The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J Biol Chem 277: 41556-41562
17. Jimenez C, Jones DR, Rodriguez-Viciana P et al. (1998) Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17: 743-753
18. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytosceleton by Ras. Cell 89: 457-467
19. Kim J, Shin DM (1997) Biomarkers of squamous cell carcinoma of the head and neck. Histol Histopathol 12: 205-218
20. Lin X, Bohle AS, Dohrmann P et al. (2001) Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg 386: 293-301
21. Mercurio AM, Rabinovitz I, Shaw LM (2001) The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol 13: 541-545
22. Mitsui H, Takuwa N, Maruyama T et al. (2001) The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int J Cancer 92: 55-62
23. Mosman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methodes 65: 5563
24. Muir C, Weiland L (1995) Upper aerodigestive tract cancers. Cancer 75: 147-153
25. Muto M, Nakane M, Hitomi Y et al. (2002) Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer. Carcinogenesis 23: 1759-1765
26. Nagpal JK, Das BR (2003) Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 39: 213-221
27. Paez J, Sellers WR. (2003) PI3-K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 115: 145-167
28. Panayotou G, Bax B, Gout I et al. (1992) Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. EMBO J 11: 4261-4272
29. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J (1997) Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol 33: 332-337
30. Pleimar CM, Hertz WM, Cambier JC (1994) Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263: 1609-1612
31. Renan MJ (1993) How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7: 139-146
32. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T et al. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99-102
33. Skolnik EY, Margolis B, Mohammadi M et al. (1991) Cloning of PI3-kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65: 83-90
34. Stein RC, Waterfield MD (2000) PI3-kinase inhibition: a target for drug development? Mol Med Today 6: 347-357
35. Su JD, Mayo LD, Donner DB, Durden DL (2003) PTEN and phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res 63: 3585-3592
36. Weber A, Wittekind C, Tannapfel A (2003) Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck. Pathol Res Pract 199: 391-397
37. Woenckhaus J, Steger K, Werner E et al. (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198: 335-342
38. Worsham MJ, Pals G, Schouten JP et al. (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129: 702-708
39. Zvelebil MJ, MacDougall L, Leevers S et al. (1996) Structural and functional diversity of phosphoinositide 3-kinases. Philos Trans R Soc Lond B Biol Sci 35: 217-223